BRPI0917491A2 - tratamento de hipertensao arterial pulmonar - Google Patents

tratamento de hipertensao arterial pulmonar

Info

Publication number: BRPI0917491A2
Authority: BR; Brazil
Prior art keywords: arterial hypertension; pulmonary arterial; hypertension treatment; treatment; pulmonary
Prior art date: 2008-08-13

Application number

BRPI0917491A

Other languages

English (en)

Inventor

Deborah Quinn

Steve Pascoe

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-08-13

Filing date

2009-08-11

Publication date

2015-12-01

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41137217&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0917491(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2009-08-11 Application filed by Novartis Ag filed Critical Novartis Ag

2015-12-01 Publication of BRPI0917491A2 publication Critical patent/BRPI0917491A2/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Virology (AREA)
Pulmonology (AREA)
Tropical Medicine & Parasitology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Toxicology (AREA)
Diabetes (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Physical Education & Sports Medicine (AREA)
AIDS & HIV (AREA)
Molecular Biology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

BRPI0917491A 2008-08-13 2009-08-11 tratamento de hipertensao arterial pulmonar BRPI0917491A2 (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US8838208P	2008-08-13	2008-08-13
US16450109P	2009-03-30	2009-03-30
PCT/US2009/053358 WO2010019540A1 (en)	2008-08-13	2009-08-11	Treatment of pulmonary arterial hypertension

Publications (1)

Publication Number	Publication Date
BRPI0917491A2 true BRPI0917491A2 (pt)	2015-12-01

Family

ID=41137217

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0917491A BRPI0917491A2 (pt)	2008-08-13	2009-08-11	tratamento de hipertensao arterial pulmonar

Country Status (16)

Country	Link
US (1)	US20110190313A1 (pt)
EP (1)	EP2315592A1 (pt)
JP (1)	JP2011530607A (pt)
KR (1)	KR20110053354A (pt)
CN (1)	CN102123711A (pt)
AU (1)	AU2009282104A1 (pt)
BR (1)	BRPI0917491A2 (pt)
CA (1)	CA2732789A1 (pt)
CL (1)	CL2011000295A1 (pt)
IL (1)	IL210922A0 (pt)
MA (1)	MA32617B1 (pt)
MX (1)	MX2011001668A (pt)
NZ (1)	NZ590839A (pt)
RU (1)	RU2011109078A (pt)
TW (1)	TW201010999A (pt)
WO (1)	WO2010019540A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2671029A1 (en)	2009-06-30	2010-12-30	James S. Baldassarre	Methods of treating term and near-term neonates having hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension
AU2014205483B2 (en)	2013-01-10	2017-11-30	Gilead Sciences, Inc.	Non-selective kinase inhibitors
JP6799201B2 (ja) *	2013-07-31	2020-12-16	アヴァリンファーマインク．	エアロゾルチロシンキナーゼ阻害剤の化合物、及びその使用
JP6483714B2 (ja)	2013-10-11	2019-03-13	ローレンスエス．ジスマン，	噴霧乾燥製剤
WO2018081567A1 (en)	2016-10-27	2018-05-03	Pulmokine, Inc.	Combination therapy for treating pulmonary hypertension
NZ753546A (en)	2016-11-08	2022-10-28	Reata Pharmaceuticals Holdings Llc	Methods of treating alport syndrome using bardoxolone methyl or analogs thereof
US20210038510A1 (en) *	2018-02-08	2021-02-11	Pulmokine, Inc.	Formulations of kinase inhibitors and prostanoids
JP2022532431A (ja)	2019-05-16	2022-07-14	エアロベイトセラピューティクス，インコーポレイテッド	イマチニブ製剤、その製造および使用
US11464776B2 (en)	2019-05-16	2022-10-11	Aerovate Therapeutics, Inc.	Inhalable imatinib formulations, manufacture, and uses thereof
US20210154193A1 (en) *	2019-11-25	2021-05-27	PHPrecisionMed, LLC	Pharmaceutical compositions for the treatment of pulmonary hypertension
TWI893032B (zh)	2019-12-13	2025-08-11	日商日本新藥股份有限公司	作為pdgf受體激酶抑制劑之化合物及組合物
EP4210684A4 (en) *	2020-09-11	2024-10-09	Pulmosim Therapeutics LLC	Compositions and methods for treating or preventing pulmonary hypertension
JP2023550407A (ja)	2020-11-17	2023-12-01	ユナイテッドセラピューティクスコーポレイション	肺高血圧向けの吸入式イマチニブ

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5521184A (en) *	1992-04-03	1996-05-28	Ciba-Geigy Corporation	Pyrimidine derivatives and processes for the preparation thereof
GB0215676D0 (en) *	2002-07-05	2002-08-14	Novartis Ag	Organic compounds
US20060154936A1 (en) *	2002-10-25	2006-07-13	Lasky Joseph A	Use of n-'5-'4-(4-methylpiperaziomethyl)-benzoylamido!-2-methylphenyl!-4-(3-pyridyl)2-pyridine-amine for the treatment of pulmonary hypertension
GB0325031D0 (en) *	2003-10-27	2003-12-03	Novartis Ag	Organic compounds
US20080114001A1 (en) *	2005-01-28	2008-05-15	Manley Paul W	Use of Pyrimidylaminobenzamides for the Treatment of Diseases that Respond to Modulation of Tie-2 Kinase Activity
JP5154408B2 (ja) *	2005-05-02	2013-02-27	ノバルティスアーゲー	好酸球増加症候群のためのピリミジルアミノベンズアミド誘導体
KR101498848B1 (ko) *	2005-12-06	2015-03-05	노파르티스 아게	신경섬유종증의 치료를 위한 피리미딜아미노벤즈아미드 유도체
KR20120049397A (ko) *	2006-11-03	2012-05-16	노파르티스 아게	단백질 키나제 억제제로서의 화합물 및 조성물

2009
- 2009-08-11 KR KR1020117005744A patent/KR20110053354A/ko not_active Withdrawn
- 2009-08-11 JP JP2011523078A patent/JP2011530607A/ja active Pending
- 2009-08-11 RU RU2011109078/04A patent/RU2011109078A/ru not_active Application Discontinuation
- 2009-08-11 EP EP09791358A patent/EP2315592A1/en not_active Withdrawn
- 2009-08-11 CN CN2009801314677A patent/CN102123711A/zh active Pending
- 2009-08-11 NZ NZ590839A patent/NZ590839A/xx not_active IP Right Cessation
- 2009-08-11 WO PCT/US2009/053358 patent/WO2010019540A1/en not_active Ceased
- 2009-08-11 CA CA2732789A patent/CA2732789A1/en not_active Abandoned
- 2009-08-11 AU AU2009282104A patent/AU2009282104A1/en not_active Abandoned
- 2009-08-11 BR BRPI0917491A patent/BRPI0917491A2/pt not_active IP Right Cessation
- 2009-08-11 US US13/058,742 patent/US20110190313A1/en not_active Abandoned
- 2009-08-11 MX MX2011001668A patent/MX2011001668A/es not_active Application Discontinuation
- 2009-08-12 TW TW098127172A patent/TW201010999A/zh unknown
2011
- 2011-01-27 IL IL210922A patent/IL210922A0/en unknown
- 2011-02-11 CL CL2011000295A patent/CL2011000295A1/es unknown
- 2011-03-07 MA MA33678A patent/MA32617B1/fr unknown

Also Published As

Publication number	Publication date
NZ590839A (en)	2013-02-22
IL210922A0 (en)	2011-04-28
AU2009282104A1 (en)	2010-02-18
KR20110053354A (ko)	2011-05-20
US20110190313A1 (en)	2011-08-04
TW201010999A (en)	2010-03-16
EP2315592A1 (en)	2011-05-04
JP2011530607A (ja)	2011-12-22
CA2732789A1 (en)	2010-02-18
MA32617B1 (fr)	2011-09-01
CL2011000295A1 (es)	2011-07-15
WO2010019540A1 (en)	2010-02-18
MX2011001668A (es)	2011-03-25
CN102123711A (zh)	2011-07-13
RU2011109078A (ru)	2012-09-20

Publication	Publication Date	Title
BRPI0917491A2 (pt)	2015-12-01	tratamento de hipertensao arterial pulmonar
EP2333141A4 (en)	2015-11-04	DRIER
EP2366044A4 (en)	2012-05-02	Dryer
EP2332943A4 (en)	2012-03-14	NOVEL CONDENSATE AMINODIHYDROTHIAZINE DERIVATIVE
EP2244670A4 (en)	2011-03-16	INTERSPINED DISTANCE MEMBER
EP2242446A4 (en)	2015-01-07	PARTIAL SLEEVE
BRPI0916763A2 (pt)	2018-02-14	dialisador
DK2201858T3 (da)	2013-11-04	Hårtørrer
BRPI0915524A2 (pt)	2016-01-26	conjunto de aerofólio
EP2256192A4 (en)	2012-06-06	CATALASE WITH TEMPERATURE TOLERANCE
BRPI0906807A2 (pt)	2015-07-14	Fibra monofilamentar
DK2318378T3 (da)	2013-11-18	Quinazolin-derivater
EP2264505A4 (en)	2014-05-07	LENS LENS
DK1987765T3 (da)	2012-12-17	Oximeter
DK2300238T3 (da)	2013-12-16	Skyggebillede-sikkerhedstræk
BRPI0819362A2 (pt)	2015-04-22	Cesta-peneira
EP2337157A4 (en)	2014-01-08	CONNECTOR
BRPI0915442A2 (pt)	2017-06-27	tamis melhorado
BRPI0912547A2 (pt)	2018-06-26	aba de fixação
BRPI0917718A2 (pt)	2016-05-31	calçado
HRP20160577T1 (hr)	2016-07-29	Liječenje osteoartritisa
ATE546371T1 (de)	2012-03-15	Holzbottich
EP2344695A4 (en)	2013-09-11	WHITENING METHOD
FI20080312L (fi)	2009-10-25	Harvesteri
ES1069830Y (es)	2009-09-03	Yurta moderna

Legal Events

Date	Code	Title	Description
2016-06-21	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.
2016-10-11	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2372 DE 21-06-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.